Extracellular Matrix Alterations in Patients With Paroxysmal and Persistent Atrial Fibrillation. Biochemical Assessment of Collagen Type-I Turnover

Journal of the American College of Cardiology

Volumn 52, Issue 3, 2008, Pages 211-215

  Kallergis, Eleftherios M ^a   Manios, Emmanuel G ^a   Kanoupakis, Emmanuel M ^a   Mavrakis, Hercules E ^a   Arfanakis, Dimitris A ^a   Maliaraki, Niki E ^a   Lathourakis, Chrisovalantis E ^a   Chlouverakis, Gregory I ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

atrial fibrillation; collagen; fibrosis

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; INTERSTITIAL COLLAGENASE; TELOPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CARBOXY TERMINAL SEQUENCE; COLLAGEN SYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEGRADATION; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; SINUS RHYTHM; STRUCTURE ANALYSIS;

ADULT; AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 46249107690     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.03.045     Document Type: Article

References (14)

1. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
2. Boldt A., Wetzel U., Lauschke J., et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 90 (2004) 400-405
3. Bishop J.E. Regulation of cardiovascular collagen deposition by mechanical forces. Mol Med Today 4 (1998) 69-75
4. López B., González A., Varo N., Laviades C., Querejeta R., and Díez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 38 (2001) 1222-1226
5. Laviades C., Varo N., Fernandez J., et al. Abnormalities of the extracellular degradation of collagen type-I in essential hypertension. Circulation 8 (1998) 535-540
6. Lindsay M.M., Maxwell P., and Dunn F.G. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 40 (2002) 136-141
7. Lijnen P., Petrov V., and Fagard R. Induction of cardiac fibrosis by transforming growth factor-b1. Mol Genet Metab 71 (2000) 418-435
8. Li Y.Y., McTiernan C.F., and Feldman A.M. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 46 (2000) 214-224
9. Wijffels M.C., Kirchhof C.J., Dorland R., and Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92 (1995) 1954-1968
10. Allessie M., Ausma J., and Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54 (2002) 230-246
11. Yu W.C., Lee S.H., Tai C.T., et al. Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 42 (1999) 470-476
12. Kostin S., Klein G., Szalay Z., Hein S., Bauer E., and Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54 (2002) 361-379
13. Janse M.J. Why does atrial fibrillation occur?. Eur Heart J 18 (1997) 12-18
14. Nagatomo Y., Carabello B.A., Coker M.L., et al. Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control. Am J Physiol 278 (2000) H151-H161